Document Detail

In vitro susceptibility of clinical isolates of Brucella melitensis to fucidic acid.
MedLine Citation:
PMID:  15856380     Owner:  NLM     Status:  MEDLINE    
Brucella species are facultative intracellular bacteria, and therefore a limited number of antibiotics are effective against these organisms. The side effects of drug combination schemes, and the incidences of relapses and therapeutic failures, have led to investigations of new drugs to treat brucellosis. The purpose of this study was to test the in vitro susceptibility of 50 Brucella melitensis isolates to fucidic acid, which has not previously been used for the treatment of brucellosis. The minimum inhibitory concentrations (MICs) of fucidic acid to 50 B. melitensis isolates that were obtained from blood and bone marrow cultures of patients with brucellosis were studied by the broth microdilution method. The MIC50 and MIC90 values for the 50 B. melitensis strains' susceptibility to fucidic acid were determined to be 0.5 and 2 microg/ml, respectively, and the MIC range was 0.125-2.0 microg/ml. Further experiments are needed to reassess the activity of fucidic acid against intracellular Brucella spp.
Ilhami Celik; Mustafa Cihangiroglu; Affan Denk; Ayhan Akbulut
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy     Volume:  11     ISSN:  1341-321X     ISO Abbreviation:  J. Infect. Chemother.     Publication Date:  2005 Apr 
Date Detail:
Created Date:  2005-04-27     Completed Date:  2005-06-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9608375     Medline TA:  J Infect Chemother     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  101-3     Citation Subset:  IM    
Department of Clinical Microbiology and Infectious Diseases, Faculty of Medicine, Firat University, Elazig, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Anti-Bacterial Agents / pharmacology*
Brucella melitensis / drug effects*
Fusidic Acid / pharmacology*
Microbial Sensitivity Tests
Middle Aged
Reg. No./Substance:
0/Anti-Bacterial Agents; 6990-06-3/Fusidic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Measles encephalitis in early pregnancy and after delivery.
Next Document:  Investigation of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR).